EUVIMEDEUVIMED entdecken
Multizentrische Studie

Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study

Andriani Charpidou, Maria Mani, Eleni Kokkotou, Lamprini Stournara, Lefkothea Stathelou, Kyriaki Antoniadou, Evangelos Argyropoulos, Konstantinos N Syrigos

Anticancer Research · 2024

DOI: 10.21873/anticanres.17010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Anticancer Research, 2024. Verfasst von Andriani Charpidou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sotiria General Hospital of Chest Disease, 3 Department of Internal Medicine of University of Athens, Oncology Unit, Athens, Greece; dcharpidou@yahoo…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Lung cancer, primarily non-small cell lung cancer (NSCLC), is the leading cause of cancer deaths globally. In Greece in 2020, 8,960 new cases were reported. NSCLC's 5-year survival rates range from 54% (stage I) to less than 2% (stage IV); however, innovative therapies like immune check points inhibitors (ICIs) and targeted treatments have notably enhanced outcomes. The aim of this study was to assess the 1st and 2nd line treatment patterns with the introduction of new treatment modalities. Additionally, we evaluated biomarker testing approaches in NSCLC. PATIENTS AND METHODS: LACHESIS was a retrospective multinational study, collecting and analyzing data from adult patients from Russia, Bulgaria, and Greece with metastatic NSCLC either newly diagnosed or relapsed from earlier stages, who had the option to undergo biomarker testing (genetic alterations/programmed death-ligand 1 protein expression levels, PD-L1), and who received 1st line treatment for squamous (SQ) or non-squamous (N-SQ) NSCLC. Subsequent lines of therapy were also reported. RESULTS: The Greek site registered retrospective data from 250 NSCLC patients, of whom 206 were newly diagnosed (ND) metastatic NSCLC patients and 44 were patients relapsed from earlier stages. Seventy-two had SQ NSCLC and 169 had N-SQ NSCLC. For these patients, treatment patterns including immunotherapy±chemotherapy combinations were recorded. Biomarker testing patterns, including genetic alterations and PD-L1 expression levels were also documented. CONCLUSION: LACHESIS provides treatment patterns and biomarker testing data. Greek patients were treated according to international guidelines, with immunotherapy as a viable option, particularly for PD-L1 levels over 50%. Biomarker testing, crucial for non-squamous (N-SQ) cases, should yield timely results for driver mutations, prioritizing patient benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsBiomarkers, TumorHumansMaleFemaleGreeceMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overBulgariaRussiaB7-H1 AntigenImmune Checkpoint InhibitorsPathology, MolecularNeoplasm Metastasis

Stichwörter der Autor:innen

Metastatic non-small cell lung cancer (NSCLC)immunotherapymolecular testingreal world evidence datatreatment patterns

Substanzen

Biomarkers, TumorB7-H1 AntigenImmune Checkpoint InhibitorsCD274 protein, human

Autor:innen und Institutionen

  • Sotiria General Hospital of Chest Disease, 3 Department of Internal Medicine of University of Athens, Oncology Unit, Athens, Greece; dcharpidou@yahoo.gr.
  • Sotiria General Hospital of Chest Disease, 3 Department of Internal Medicine of University of Athens, Oncology Unit, Athens, Greece.
  • Novartis (Hellas) S.A.C.I., Athens, Greece.

Zitieren

APA

Charpidou, A., Mani, M., Kokkotou, E., Stournara, L., Stathelou, L., Antoniadou, K., Argyropoulos, E., & Syrigos, K. N. (2024). Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study. Anticancer Research. https://doi.org/10.21873/anticanres.17010

Vancouver

Charpidou A, Mani M, Kokkotou E, Stournara L, Stathelou L, Antoniadou K, et al. Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study. Anticancer Research. 2024. doi:10.21873/anticanres.17010

BibTeX
@article{Charpidou2024,
  author = {Charpidou, Andriani and Mani, Maria and Kokkotou, Eleni and Stournara, Lamprini and Stathelou, Lefkothea and Antoniadou, Kyriaki and Argyropoulos, Evangelos and Syrigos, Konstantinos N},
  title = {Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17010}
}
Kostenlos starten →